NCT02545621View on ClinicalTrials.gov

A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Acute Respiratory Distress SyndromeMechanical Ventilation
Interventions
OTHER

RAGE TXNIP Inflammasome axis

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study | Biotech Hunter | Biotech Hunter